HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
PE-22-28HPLC ≥ 99%MS confirmed5mg / 10mg
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | PE-22-28 |
|---|---|
| CAS number | 1801959-12-5 |
| Molecular formula | C35H55N11O9 |
| Molecular weight | 773.9 g/mol |
| Sequence | Gly-Val-Ser-Trp-Gly-Leu-Arg (GVSWGLR) |
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 5mg / 10mg |
| Documentation | Batch-document availability confirmed by product, specification and applicable lot |
| Distribution scope | Research use, worldwide |
| Storage | Store lyophilized powder at -20°C, protected from light and moisture; stable long-term when sealed. After reconstitution, keep at 2-8°C and use within a short period. Avoid repeated freeze-thaw cycles. |
MOQ & lead time
| Tier | Quantity | Lead time |
|---|---|---|
| OEM lot | 50 kits (500 vials) | 3–7 days |
| Production lot | 500–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Supplied as a research-use peptide. Every quote confirms current-batch COA, purity, destination market and buyer track before invoicing.
Overview
About PE-22-28.
PE-22-28 is a seven-residue peptide corresponding to residues 22-28 of spadin, the endogenous sortilin-derived peptide, and is often called "mini-spadin." It acts as a selective blocker of the TREK-1 (TWIK-related potassium) channel, a two-pore-domain K+ channel studied as a target in neurogenesis, synaptic-signaling, and mood-related preclinical research.
Documentation
Batch documentation support for PE-22-28 lots.
batch-document availability confirmed by product, specification and applicable lot. Distribution scope confirmed before invoicing.
MS identity
Mass spectrometry identity confirmation against the PE-22-28 reference profile.
Lot traceability
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
PE-22-28 — frequently asked by B2B buyers.
What exactly is PE-22-28?
PE-22-28 is a synthetic heptapeptide (sequence GVSWGLR) corresponding to residues 22-28 of spadin, a sortilin-derived peptide, and is sometimes called mini-spadin. In preclinical research it is characterized as a selective TREK-1 potassium-channel inhibitor. All material is supplied strictly for laboratory and research use.
What purity and documentation do you provide?
For the applicable lot, Pepti confirms whether available documentation includes a batch-linked COA including RP-HPLC purity target (≥99%; actual result shown in lot documents) and mass-spectrometry identity confirmation matching the C35H55N11O9 / ~773.9 g/mol profile. Additional data such as residual-solvent, water-content, or endotoxin (only if specifically ordered and tested) testing can be provided on request for OEM programs.
What vial size and MOQ are available?
Standard catalog formats are 5 mg and 10 mg lyophilized vials, with a minimum order of 50 kits (500 vials).
Can you private-label or customize PE-22-28?
Yes. We support OEM and private-label programs including custom vial fill, labeling, and packaging. Analogs and sequence modifications built on the GVSWGLR core can be scoped on RFQ, subject to feasibility review.
How is PE-22-28 shipped and handled for compliance?
Lyophilized material ships with documentation identifying it as a research-use-only chemical, not for consumer or veterinary use. Cold-chain or ambient shipping is selected by destination and transit time, and export paperwork is prepared per the buyer's jurisdiction.
Related compounds
Related research peptides.
COA library search
Search public COAs for this product.
The public COA library is being expanded by product and specification. Use the search link below to check current public records for this item.